Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADMA, ARB, and statin effects on renal endothelial dysfunction in hypertensive adults with mild renal insufficiency
NL-OMON32808Recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Sep 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of eprosartan, rosuvastatin and NG-monomethyl-L-arginine in hypertension (HTN) and Renal Insufficiency (RI) (4 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Basal renal perfusion, Fractional change in renal perfusion after intrarenal L-NMMA infusion and 6 more. Started Sep 2009; status: recruiting.
02
Drugs
eprosartanrosuvastatinNG-monomethyl-L-arginine
03
Conditions
hypertension (HTN)Renal Insufficiency (RI)
Beyond the preview
Go deeper on NL-OMON32808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32808.